Switching Biological Therapies in Adults with Severe Asthma: What Are the Dilemmas and Is It Worthwhile?
Ann Am Thorac Soc
.
2022 Dec;19(12):1965-1970.
doi: 10.1513/AnnalsATS.202203-251PS.
Authors
John Politis
1
,
Philip G Bardin
1
Affiliation
1
Monash Lung Sleep Allergy & Immunology, Monash Medical Centre and University, Melbourne, Victoria, Australia.
PMID:
35984426
DOI:
10.1513/AnnalsATS.202203-251PS
No abstract available
MeSH terms
Adult
Anti-Asthmatic Agents* / therapeutic use
Asthma* / drug therapy
Biological Therapy
Humans
Substances
Anti-Asthmatic Agents